FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Enrique Soto: New ASCO Global Guideline on Geriatric Assessment

Enrique Soto

Katy Rezvani: Comprehensive Overview of Engineered Natural Killer Cells for Cancer Therapy

Katy Rezvani

Zihai Li: First-In-Human Anti-GARP CAR-T Trial for Patients With Relapsed GBM

Zihai Li

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

Iza-bren (EGFR×HER3 bispecific ADC) 303 Study: Late-breaking ESMO presentation, The Lancet publication, and press-conference Q&A highlights

iza-bren egfrxher3 bispecific press release

OncoCalendar

« All Events

  • This event has passed.

ESMO Targeted Anticancer Therapies Asia Congress 2025

Jul 18 • 12:00 AM - Jul 20 • 12:00 AM
ESMO Targeted Anticancer Therapies Asia Congress 2025

The ESMO TAT Asia Congress 2025 will be held in Hong Kong SAR, China on July 18-20. This multi-stakeholder forum brings together key players in cancer drug development, providing a platform to share the latest advances in early clinical trials across the region.

The congress, organized by the European Society for Medical Oncology, will feature in-depth discussions on vital topics such as innovation, digital transformation, research methodology, business insights, regulation, and public policy. ESMO TAT Asia aims to drive progress in cancer treatment and research.

Set in the vibrant city of Hong Kong, the congress promises to be a dynamic gathering of industry leaders, academics, clinicians, and regulators, fostering international cooperation and accelerating anticancer research.

Don’t miss this opportunity to be part of the conversation and stay tuned for registration details.

Find more information about ESMO at OncoDaily.com.

Details

Start:
Jul 18 • 12:00 AM
End:
Jul 20 • 12:00 AM
Website:
https://www.esmo.org/meeting-calendar/esmo-targeted-anticancer-therapies-asia-congress-2025

Organizer

European Society For Medical Oncology (ESMO)
Phone
+41 (0)91 973 19 00
Email
esmo@esmo.org
View Organizer Website